Replies to post #20003 on $Bob's and Jbem's Bitchin' Bios

[kei]

should be bought out by 'P' ...KTOV

[ash111]

KTOV thanks buckiii2,and KIT-302 beats Pfizer's drug.Today, there is no drug on the market that handles both things together - in pain as a result of osteoarthritis and high blood pressure. Therefore, the KIT-302 will be the only drug with indication for the treatment of pain while reducing the risk of heart attack and stroke may even brought a dying patient.

40% of docs "will prescribe over Celebrex",25 percent of doc's that won't RX Celebrex would RX KIT.

I think a BO on the table too(I would say 300m the least imo for a billion dollar drug. vs 24m current cap).

[kei]

KTOV - KTOVW .. former FDA officer and a former FDA chemist are in the management